IL143499A0 - Liposomic niflumic acid-new transdermal anti-inflammatory medicine - Google Patents

Liposomic niflumic acid-new transdermal anti-inflammatory medicine

Info

Publication number
IL143499A0
IL143499A0 IL14349999A IL14349999A IL143499A0 IL 143499 A0 IL143499 A0 IL 143499A0 IL 14349999 A IL14349999 A IL 14349999A IL 14349999 A IL14349999 A IL 14349999A IL 143499 A0 IL143499 A0 IL 143499A0
Authority
IL
Israel
Prior art keywords
liposomic
niflumic acid
inflammatory medicine
new transdermal
transdermal anti
Prior art date
Application number
IL14349999A
Other languages
English (en)
Original Assignee
Gerolymatos P N Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerolymatos P N Sa filed Critical Gerolymatos P N Sa
Publication of IL143499A0 publication Critical patent/IL143499A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14349999A 1998-12-24 1999-12-22 Liposomic niflumic acid-new transdermal anti-inflammatory medicine IL143499A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR98100469 1998-12-24
PCT/GR1999/000048 WO2000038681A1 (en) 1998-12-24 1999-12-22 Liposomic niflumic acid - new transdermal anti-inflammatory medicine

Publications (1)

Publication Number Publication Date
IL143499A0 true IL143499A0 (en) 2002-04-21

Family

ID=10943556

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14349999A IL143499A0 (en) 1998-12-24 1999-12-22 Liposomic niflumic acid-new transdermal anti-inflammatory medicine

Country Status (17)

Country Link
EP (1) EP1140089A1 (ja)
JP (1) JP2002533394A (ja)
KR (1) KR20010089889A (ja)
CN (1) CN1331592A (ja)
AU (1) AU1673400A (ja)
BR (1) BR9917006A (ja)
CA (1) CA2357765A1 (ja)
CZ (1) CZ20012240A3 (ja)
GR (1) GR1003359B (ja)
HU (1) HUP0104853A3 (ja)
IL (1) IL143499A0 (ja)
IS (1) IS5964A (ja)
MX (1) MXPA01006462A (ja)
NO (1) NO20013015D0 (ja)
PL (1) PL349344A1 (ja)
SK (1) SK7962001A3 (ja)
WO (1) WO2000038681A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004047802A2 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Liposomal formulations
CN1812766A (zh) * 2003-04-25 2006-08-02 宾州研究基金会 用于全身传递使生长停滞的、衍生于脂质的生物活性化合物的方法和系统
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JP4791082B2 (ja) * 2005-05-30 2011-10-12 株式会社クラレ リポソームおよびそれを含む皮膚外用剤
JP4931369B2 (ja) * 2005-05-31 2012-05-16 ポーラ化成工業株式会社 リポソームおよびそれを含む処置用の組成物
PT1888033E (pt) 2005-06-09 2014-05-15 Meda Ab Método e composição para tratamento de distúrbios inflamatórios
EP2598128B1 (en) 2010-07-28 2018-03-28 Life Technologies Corporation Anti- viral azide-containing compounds
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
KR20140129054A (ko) 2012-01-26 2014-11-06 라이프 테크놀로지스 코포레이션 바이러스의 감염성을 증가시키는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
EP0225162B1 (en) * 1985-11-27 1992-01-22 Ethicon, Inc. Inhibition of post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug
DE3778972D1 (de) * 1986-06-12 1992-06-17 Liposome Co Inc Mittel unter verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer arzneistoffe.
EP0825852B1 (en) * 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition

Also Published As

Publication number Publication date
GR1003359B (el) 2000-04-10
CA2357765A1 (en) 2000-07-06
HUP0104853A2 (hu) 2002-05-29
KR20010089889A (ko) 2001-10-12
NO20013015L (no) 2001-06-18
EP1140089A1 (en) 2001-10-10
MXPA01006462A (es) 2002-06-04
CZ20012240A3 (cs) 2001-11-14
AU1673400A (en) 2000-07-31
CN1331592A (zh) 2002-01-16
NO20013015D0 (no) 2001-06-18
IS5964A (is) 2001-06-08
BR9917006A (pt) 2001-10-30
WO2000038681A1 (en) 2000-07-06
PL349344A1 (en) 2002-07-15
JP2002533394A (ja) 2002-10-08
HUP0104853A3 (en) 2003-05-28
SK7962001A3 (en) 2002-02-05

Similar Documents

Publication Publication Date Title
PL340337A1 (en) Drugs
EP0941039A4 (en) TRANSDERMAL ADMINISTRATION OF 7alpha-METHYL-19-NORTESTOSTERONE ("MENT")
EP1077996A4 (en) GENE EDG3sb HUMAN
EP1145714A4 (en) DRUGS
GB2333960B (en) Poultice
GB9925893D0 (en) Medicine packs
PL349344A1 (en) Liposomic niflumic acid - new transdermal anti-inflammatory medicine
HK1041403A1 (zh) 藥劑注入器
GB9808665D0 (en) Therapeutic compounds
HUP0101341A3 (en) New drug combinations
IL126671A0 (en) Drug preferably for inhibiting inflammation
EP1091783A4 (en) DISTRIBUTOR OF DRUGS
GB9810920D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
AU2965199A (en) Medicine mini-chest
IL126732A0 (en) Pro drug
GB9804930D0 (en) Disposable display system
GB9821179D0 (en) Therapeutic use
GB9907234D0 (en) Drug assay
GB9808667D0 (en) Therapeutic compounds
GB9812664D0 (en) Therapeutic use
AUPO664397A0 (en) Transdermal anti-inflammatory drugs
GB9819621D0 (en) Medicine
GB9724817D0 (en) Transdermal dosage form